Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC-ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project

被引:67
|
作者
Wang, Yintang [1 ]
Geng, Yu [1 ]
Zhang, Ou [1 ]
Xu, Qin [2 ,3 ]
Xue, Yajun [1 ]
Zhou, Boda [1 ]
Zhang, Ping [1 ]
Li, Aihua
Li, Bao
Xu, Biao
Han, Guangshu
Li, Bin
Liu, Bin
Wang, Bin
Fu, Bing
Yu, Bo
Yang, Bosong
Luo, Caidong
Wang, Changqian
Liu, Changyong
Liang, Chuanliang
Gao, Chuanyu
Lai, Chunlin
Wang, Chuntong
Zhang, Chunyan
Wu, Chunyang
Zhang, Congliang
Bin, Cui
Huang, Lan
Peng, Daoquan
Xu, Dawen
Wu, Di
Zhu, Dongmei
Chai, Dongsheng
Li, Dongyan
Tang, Fakuan
Xiao, Jun
Zhao, Fang
Huang, Fangfang
Meng, Fanju
Li, Fengwei
Gan, Fudong
Xu, Gang
Sang, Gengsheng
Ma, Genshan
Zhang, Guixia
Tao, Guizhou
Li, Guo
Chen, Guoduo
Xin, Guoqin
机构
[1] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Cardiol, 168 Litang Rd, Beijing 102218, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
关键词
P2Y12 receptor inhibitors; Non-ST-segment elevation acute coronary syndrome; Loading dose; Outcome; Therapy; DUAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; ARTERY-DISEASE; FOCUSED UPDATE; 2017; ESC; CLOPIDOGREL; ASPIRIN; ANGIOPLASTY; GUIDELINES;
D O I
10.1186/s40001-023-01025-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background The association between P2Y12 receptor inhibitors reloading and in-hospital outcomes in non-ST-segment elevation acute coronary syndrome (NSTEACS) patients who were on chronic P2Y12 receptor inhibitors therapy remained underdetermined.Methods The Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS project) is a national registry active from November 2014 to December 2019. 4790 NSTEACS patients on chronic P2Y12 receptor inhibitors therapy were included. Cox proportional hazard models, Kaplan-Meier curves, and subgroup analyses were conducted.Results The NSTEACS patients who received reloading of P2Y12 receptor inhibitors were younger and had fewer comorbid conditions. The reloading group had a lower risk of major adverse cardiac events (MACE) (0.51% vs. 1.43%, P = 0.007), and all-cause death (0.36% vs. 0.99%, P = 0.028), the risks of myocardial infarction and major bleeding were not significantly different between patients with and without reloading. In survival analysis, a lower cumulative risk of MACE could be identified (Log-rank test, P = 0.007) in reloading group. In the unadjusted Cox model, reloading P2Y12 receptor inhibitors was associated with a decreased risk of MACE [HR, 0.35; 95% CI 0.16-0.78; (P = 0.010)] and all-cause death [HR, 0.37; 95% CI 0.14-0.94; (P = 0.036)]. Reloading of P2Y12 receptor inhibitors was associated with a decreased risk of MACE in most of the subgroups.Conclusions In NSTEACS patients already taking P2Y12 receptor inhibitors, we observed a decreased risk of in-hospital MACEs and all-cause mortality and did not observe an increased risk of major bleeding, with reloading. The differential profile in the two groups might influence this association and further studies are warranted.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
    Yintang Wang
    Yu Geng
    Ou Zhang
    Qin Xu
    Yajun Xue
    Boda Zhou
    Ping Zhang
    European Journal of Medical Research, 28
  • [2] The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project
    Lijiao Yang
    Nan Ye
    Guoqin Wang
    Weijing Bian
    Fengbo Xu
    Dong Zhao
    Jing Liu
    Yongchen Hao
    Jun Liu
    Na Yang
    Hong Cheng
    BMC Cardiovascular Disorders, 21
  • [3] The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project
    Yang, Lijiao
    Ye, Nan
    Wang, Guoqin
    Bian, Weijing
    Xu, Fengbo
    Zhao, Dong
    Liu, Jing
    Hao, Yongchen
    Liu, Jun
    Yang, Na
    Cheng, Hong
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [4] Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
    Tarantini, Giuseppe
    Mojoli, Marco
    Varbella, Ferdinando
    Caporale, Roberto
    Rigattieri, Stefano
    Ando, Giuseppe
    Cirillo, Plinio
    Pierini, Simona
    Santarelli, Andrea
    Sganzerla, Paolo
    Cacciavillani, Luisa
    Babuin, Luciano
    De Cesare, Nicoletta
    Limbruno, Ugo
    Massoni, Alberto
    Rognoni, Andrea
    Pavan, Daniela
    Belloni, Flavia
    Cernetti, Carlo
    Favero, Luca
    Saia, Francesco
    Fovino, Luca Nai
    Masiero, Giulia
    Roncon, Loris
    Gasparetto, Valeria
    Ferlini, Marco
    Ronco, Federico
    Rossini, Roberta
    Canova, Paolo
    Trabattoni, Daniela
    Russo, Alessandra
    Guiducci, Vincenzo
    Penzo, Carlo
    Tarantino, Fabio
    Mauro, Ciro
    Corrada, Elena
    Esposito, Giovanni
    Marchese, Alfredo
    Berti, Sergio
    Martinato, Matteo
    Azzolina, Danila
    Gregori, Dario
    Angiolillo, Dominick J.
    Musumeci, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (21) : 2450 - 2459
  • [5] Association between stress hyperglycemia ratio and in-hospital outcomes: findings from the improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome(CCC-ACS) Project
    Wen-Jie WANG
    Ke-Xin WANG
    Jia-Long NIU
    Yi-Xuan LIU
    Hai-Long GE
    Hua SHEN
    CCC-ACS investigators
    JournalofGeriatricCardiology, 2024, 21 (06) : 658 - 668
  • [6] Quality of Care for Patients With Non-ST-Segment Elevation Acute Coronary Syndrome in China: Findings From Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
    Yang, Na
    Liu, Jing
    Liu, Jun
    Hao, Yongchen
    Smith, Sidney
    Huo, Yong
    Fonarow, Gregg
    Ge, Junbo
    Taubert, Kathryn
    Morgan, Louise
    Han, Yaling
    Ma, Changsheng
    Zhao, Dong
    CIRCULATION, 2018, 138
  • [7] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Is Clinically Justified
    Valgimigli, Marco
    CIRCULATION, 2014, 130 (21) : 1891 - 1903
  • [8] Pretreatment with P2Y12 inhibitors in non-ST-segment elevation acute coronary syndrome: Time to revise the guidelines?
    Cayla, Guillaume
    Collet, Jean-Philippe
    Silvain, Johanne
    Montalescot, Gilles
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (01) : 1 - 3
  • [9] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Is Clinically Justified Response
    Collet, Jean-Philippe
    Silvain, Johanne
    Bellemain-Appaix, Anne
    Montalescot, Gilles
    CIRCULATION, 2014, 130 (21) : 1903 - 1903
  • [10] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment with P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy
    Collet, Jean-Philippe
    Silvain, Johanne
    Bellemain-Appaix, Anne
    Montalescot, Gilles
    CIRCULATION, 2014, 130 (21) : 1904 - 1914